17 January 2020

ASCCT 2018: 7th Annual Meeting

ASCCT 2018: 7th Annual meeting of the American Society for Cellular and Computational Toxicology  

Edited by Erin Hill, David Allen, Kristie Sullivan

Overview of the 7th Annual Meeting of the American Society for Cellular and Computational Toxicology E.L. Berg, D. Allen, K. Sullivan, E. HillIn. Press, Journal Pre-proof, Available online 23 November 2019 (Editorial)

Nonanimal toxicology testing approaches for traditional and deemed tobacco products in a complex regulatory environment: Limitations, possibilities, and future directions Dana Lauterstein, Matthew Savidge, Yanling Chen, Roxana Weil, R. Philip Yeager. February 2020

Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT) G.-E. Costin, E. Hill, J. Brown, A.J. Clippinger. February 2020

Predictive toxicology for regulatory decisions: Implementing new approaches at US Food and Drug Administration Suzanne C. Fitzpatrick, DABT, ERT,US Food and Drug Administration. March 2020

Related content

Fraudulent e-mails offering ESTIV Congress attendance lists – be cautious!

Be aware that there are fraudulent e-mails sent out by scammers offering the congress attendance lists, accommodation, services etc

ESTIV Best Abstract Award at the VHP 2026 Conference

The award, valued at €300, will recognise an outstanding abstract in the field of in silico toxicology and New Approach Methodologies (NAMs).

Special Issue completed – ESTIV 2024: The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment

  • News

ESTIV would like to extend its heartfelt thanks to all contributors to this special issue, which highlights some of the science and activities that took place during the congress.

Silver Sponsor

Communication partners

Memorandum of Understanding